Praveg Ltd.
BSE: PRAVEG
Prev Close
517.3
Open Price
510.3
Volume
27,618
Today Low / High
503 / 513.95
52 WK Low / High
436.25 / 927.95
Range
480 - 530
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 505.2, reflecting a change of -12.1 (-2.33907%). The expected target range on the BSE is 480 - 530. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.
Praveg Ltd. Graph
Praveg Ltd. Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Praveg Ltd. T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 505.20, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 505.20 | 510.25 | 459.23 - 561.28 |
| 515.30 | 412.24 - 618.36 | ||
| 520.36 | 364.25 - 676.46 | ||
| Bearish Scenario | 505.20 | 500.15 | 450.13 - 550.16 |
| 495.10 | 396.08 - 594.12 | ||
| 490.04 | 343.03 - 637.06 |
Overview of Praveg Ltd.
ISIN
INE722B01019
Industry
Medical - Pharmaceuticals
Vol.Avg
83,629
Market Cap
13,206,281,640
Last Dividend
1
Official Website
IPO Date
DCF Diff
966.08
DCF
-457
Financial Ratios Every Investor Needs
Stock Dividend of PRAVEG
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2024-09-23 | September 23, 24 | 1 | 1 | 2024-09-23 | 2024-10-01 | |
| 2023-09-15 | September 15, 23 | 4.5 | 4.5 | 2023-09-15 | 2023-10-22 | |
| 2022-11-21 | November 21, 22 | 4 | 4 | 2022-11-21 | 2022-12-28 | |
| 2021-07-15 | July 15, 21 | 2 | 2 | 2021-07-16 | 2021-08-22 | |
| 2021-02-15 | February 15, 21 | 2 | 2 | 2021-02-16 | 2021-03-10 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 167.18 Cr | 76.42 Cr | 90.76 Cr | 0.5429 | 0.00 Cr | 0.00 Cr | 21.78 Cr | 15.33 Cr | 0.00 | 56.88 Cr | 0.0917 |
| 2024-03-31 | 91.60 Cr | 38.14 Cr | 53.46 Cr | 0.5837 | 0.00 Cr | 1.61 Cr | 18.53 Cr | 13.00 Cr | 5.78 | 32.14 Cr | 0.1419 |
| 2023-03-31 | 84.48 Cr | 41.27 Cr | 43.21 Cr | 0.5114 | 0.00 Cr | 0.78 Cr | 39.32 Cr | 28.43 Cr | 14.78 | 45.30 Cr | 0.3366 |
| 2022-03-31 | 45.25 Cr | 24.83 Cr | 20.42 Cr | 0.4512 | 0.00 Cr | 1.05 Cr | 17.04 Cr | 12.24 Cr | 6.62 | 19.76 Cr | 0.2705 |
| 2021-03-31 | 45.32 Cr | 27.64 Cr | 17.67 Cr | 0.3900 | 0.00 Cr | 1.32 Cr | 14.43 Cr | 10.74 Cr | 5.81 | 16.24 Cr | 0.2370 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 12.65 Cr | 609.00 Cr | 130.16 Cr | 463.2237 Cr | 77.26 Cr | 64.61 Cr | 12.22 Cr | 404.59 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 58.3367 Cr |
| 2024-03-31 | 64.40 Cr | 364.59 Cr | 76.75 Cr | 287.8359 Cr | 62.13 Cr | -2.26 Cr | 15.63 Cr | 205.52 Cr | 1.49 Cr | 0.00 Cr | 0.10 Cr | 12.0445 Cr |
| 2023-03-31 | 4.90 Cr | 125.61 Cr | 13.15 Cr | 112.4610 Cr | 1.84 Cr | -3.06 Cr | 14.16 Cr | 65.04 Cr | 0.00 Cr | 0.00 Cr | 0.10 Cr | 12.1254 Cr |
| 2022-03-31 | 0.17 Cr | 37.88 Cr | 10.28 Cr | 27.6023 Cr | 5.53 Cr | 5.09 Cr | 4.83 Cr | 15.73 Cr | 0.13 Cr | 0.00 Cr | 0.10 Cr | 8.2709 Cr |
| 2021-03-31 | 9.14 Cr | 26.98 Cr | 7.92 Cr | 19.0573 Cr | 3.79 Cr | -5.40 Cr | 4.31 Cr | 5.37 Cr | 0.05 Cr | 0.00 Cr | 0.10 Cr | 5.3400 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 32.5365 Cr | -242.5088 Cr | 158.2211 Cr | -244.8066 Cr | -51.7512 Cr | 12.6460 Cr | -277.3431 Cr | 20.9815 Cr | 10.1002 Cr | -2.5826 Cr | -0.1169 Cr |
| 2024-03-31 | 17.4198 Cr | -177.8734 Cr | 220.3300 Cr | -157.7228 Cr | 59.4955 Cr | 64.3972 Cr | -175.1426 Cr | 12.9998 Cr | -0.3645 Cr | -10.1878 Cr | -0.3577 Cr |
| 2023-03-31 | 25.2716 Cr | -72.5993 Cr | 52.0572 Cr | -30.1481 Cr | 4.7295 Cr | 4.9017 Cr | -37.6285 Cr | 28.4330 Cr | -2.9078 Cr | -7.3936 Cr | -7.3087 Cr |
| 2022-03-31 | 6.6122 Cr | -13.1285 Cr | -2.4564 Cr | -0.9989 Cr | -8.9727 Cr | 0.1722 Cr | -7.6112 Cr | 12.2420 Cr | 2.4348 Cr | -3.6968 Cr | -0.1477 Cr |
| 2021-03-31 | 14.9547 Cr | -0.4881 Cr | -8.3405 Cr | 14.6722 Cr | 6.3735 Cr | 9.1449 Cr | -0.4928 Cr | 10.7406 Cr | -1.0049 Cr | -6.4694 Cr | -1.8424 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 58.06 Cr | 28.85 Cr | 29.22 Cr | 0.5032 | 5.64 Cr | 4.06 Cr | 0.00 | 16.60 Cr | 0.0699 |
| 2024-12-31 | 54.28 Cr | 21.16 Cr | 33.11 Cr | 0.6100 | 14.70 Cr | 9.09 Cr | 4.08 | 22.07 Cr | 0.1674 |
| 2024-09-30 | 31.44 Cr | 16.09 Cr | 15.35 Cr | 0.4881 | 0.07 Cr | 1.42 Cr | 0.55 | 10.58 Cr | 0.0450 |
| 2024-06-30 | 23.40 Cr | 19.94 Cr | 3.46 Cr | 0.1477 | 1.37 Cr | 0.76 Cr | 0.30 | 7.62 Cr | 0.0326 |
| 2024-03-31 | 32.52 Cr | 22.10 Cr | 10.42 Cr | 0.3204 | 7.15 Cr | 1.64 Cr | 0.73 | 9.46 Cr | 0.0504 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 12.65 Cr | 7.27 Cr | 19.92 Cr | 51.03 Cr | 12.22 Cr | 127.81 Cr | 404.59 Cr | 609.00 Cr | 130.16 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 118.54 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -451.73 Cr |
| 2024-09-30 | 55.29 Cr | 68.27 Cr | 123.57 Cr | 33.94 Cr | 12.37 Cr | 199.96 Cr | 306.17 Cr | 562.30 Cr | 110.58 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 103.11 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -287.84 Cr |
| 2024-03-31 | 64.40 Cr | 38.71 Cr | 103.11 Cr | 20.90 Cr | 15.63 Cr | 149.77 Cr | 205.52 Cr | 364.59 Cr | 76.75 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 9.09 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 1.42 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 0.76 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 1.64 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 8.10 Cr | 7.67 Cr | 0.00 Cr | 0.00 Cr | 7.67 Cr | 32.29 Cr | 24.62 Cr | 0.00 Cr | 7.67 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Pharmaceuticals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| MedPlus Health Services Limited | MEDPLUS | ₹873.65 | ₹104,570,514,580.00 | ₹422,805.00 |
Key Executives
Gender: male
Year Born: 1974
Gender: male
Year Born: 1988
Gender: male
Year Born: 1976
Gender: female
Year Born: 1978
Gender: male
Year Born:
Gender: male
Year Born:
FAQs about Praveg Ltd.
The CEO is Mr. Vishnukumar Vitthaldas Patel.
The current price is ₹505.20.
The range is ₹436.25-927.95.
The market capitalization is ₹1,320.63 crores.
The dividend yield is 0.20%.
The P/E ratio is 80.70.
The company operates in the Healthcare sector.
Overview of Praveg Ltd. (ISIN: INE722B01019) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹1,320.63 crores and an average daily volume of 83,629 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹1.